Back
Neurocrine Biosciences Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
60
NBIX
Neurocrine Biosciences
Last Price:
$133.55
Seasonality Move:
3.15%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Neurocrine Biosciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 131.75 | Sell |
| 20-day SMA: | 128.74 | Buy |
| 50-day SMA: | 124.23 | Buy |
| 200-day SMA: | 122.02 | Buy |
| 8-day EMA: | 103.57 | Buy |
| 20-day EMA: | 60.02 | Buy |
| 50-day EMA: | 28.36 | Buy |
| 200-day EMA: | 7.74 | Buy |
Neurocrine Biosciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 35.02 | Buy |
| Relative Strength Index (14 RSI): | 58.14 | Buy |
| Chaikin Money Flow: | -602464 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Neurocrine Biosciences Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Neurocrine Biosciences Stock
Is Neurocrine Biosciences Stock a Buy?
-
Neurocrine Biosciences share price is 131.24 while NBIX 8-day simple moving average is 131.75, which is a Sell signal.
-
The stock price of NBIX is 131.24 while Neurocrine Biosciences 20-day SMA is 128.74, which makes it a Buy.
-
Neurocrine Biosciences 50-day simple moving average is 124.23 while NBIX share price is 131.24, making it a Buy technically.
-
NBIX stock price is 131.24 and Neurocrine Biosciences 200-day simple moving average is 122.02, creating a Buy signal.
NBIX Technical Analysis vs Fundamental Analysis
Buy
60
Neurocrine Biosciences (NBIX)
is a Buy
Is Neurocrine Biosciences a Buy or a Sell?
-
Neurocrine Biosciences stock is rated a BuyThe current Neurocrine Biosciences [NBIX] share price is $131.24. The Score for NBIX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Neurocrine Biosciences Stock Info
Market Cap:
13B
Price in USD:
131.24
Share Volume:
629.5K
Neurocrine Biosciences 52-Week Range
52-Week High:
157.98
52-Week Low:
84.23
Buy
60
Neurocrine Biosciences (NBIX)
is a Buy
Neurocrine Biosciences Share Price Forecast
-
What is the Neurocrine Biosciences stock price today?The Neurocrine Biosciences stock price is 131.24 USD today.
-
Will NBIX stock go up or go down?Neurocrine Biosciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Neurocrine Biosciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Neurocrine Biosciences is not overvalued.
Is Neurocrine Biosciences Stock a Buy?
-
Neurocrine Biosciences share price is 131.24 while NBIX 8-day exponential moving average is 103.57, which is a Buy signal.
-
The stock price of NBIX is 131.24 while Neurocrine Biosciences 20-day EMA is 60.02, which makes it a Buy.
-
Neurocrine Biosciences 50-day exponential moving average is 28.36 while NBIX share price is 131.24, making it a Buy technically.
-
NBIX stock price is 131.24 and Neurocrine Biosciences 200-day simple moving average is 7.74, creating a Buy signal.
Fundamental Analysis of Neurocrine Biosciences
Is Neurocrine Biosciences a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.27 per share, a decrease this year of $0.52 per share, and an increase next year of $2.30 per share.
Technical Analysis of Neurocrine Biosciences
Should I short Neurocrine Biosciences stock?
-
NBIX Moving Average Covergence Divergence (MACD) indicator is 35.02, suggesting Neurocrine Biosciences is a Buy
-
Neurocrine Biosciences Relative Strength Index (RSI) is 58.14, which suggest Neurocrine Biosciences is overbought
-
The Bollinger Bands (25) for Neurocrine Biosciences is ( - ), which suggest Neurocrine Biosciences is a Buy
-
The Bollinger Bands (100) for Neurocrine Biosciences is ( - ), which suggest Neurocrine Biosciences is a Buy
* Neurocrine Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.